Small-Cap Device Companies: The Roach Motel of Investing
As the value of big company stocks soar, small-cap device stocks have become a pariah. Not only do big company stocks provide great returns, but big investors are beginning to value liquidity and to turn away from small company stocks because they provide no liquidity.
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.